en
Scientific article
English

Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients

Published inAnnals of the rheumatic diseases, vol. 71, no. 6, p. 997-999
Publication date2012
Abstract

After inadequate response to an antitumour necrosis factor (aTNF) agent for treatment of rheumatoid arthritis (RA), rheumatologists can choose an alternative aTNF or a biological agent with another mode of action (non-aTNF biological (non-aTNF-Bio)).

Keywords
  • Adult
  • Aged
  • Antibodies, Monoclonal, Humanized/administration & dosage/pharmacokinetics
  • Antirheumatic Agents/administration & dosage/pharmacokinetics
  • Arthritis, Rheumatoid/drug therapy
  • Female
  • Glucocorticoids/administration & dosage/pharmacokinetics
  • Humans
  • Immunoconjugates/administration & dosage/pharmacokinetics
  • Isoxazoles/administration & dosage/pharmacokinetics
  • Male
  • Methotrexate/administration & dosage/pharmacokinetics
  • Middle Aged
  • Prednisone/administration & dosage/pharmacokinetics
  • Proportional Hazards Models
  • Registries
  • Remission Induction
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha/antagonists & inhibitors
Citation (ISO format)
MARTIN-DU-PAN, Sophie Marie Catherine et al. Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients. In: Annals of the rheumatic diseases, 2012, vol. 71, n° 6, p. 997–999. doi: 10.1136/annrheumdis-2011-200882
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0003-4967
577views
0downloads

Technical informations

Creation11/15/2013 4:23:00 PM
First validation11/15/2013 4:23:00 PM
Update time03/14/2023 8:45:48 PM
Status update03/14/2023 8:45:47 PM
Last indexation01/16/2024 8:38:02 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack